Repligen updates FY 2024 EPS guidance to 1.420-1.490 and revenue guidance to $620M-$650M.
Repligen (NASDAQ:RGEN) updated FY 2024 earnings guidance, providing EPS guidance of 1.420-1.490, compared to consensus EPS estimate of 1.460. Revenue guidance is $620M-$650M compared to consensus revenue estimate of $635.6M. RGEN traded up $0.74 during trading on Friday, with a market cap of $9.33B, P/E ratio of 668.23, and beta of 1.03.
May 05, 2024
3 Articles